Ally Bridge Group’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History

Ally Bridge Group’s Portfolio MDVL Stock Details MDVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-117,897	Closed	-$529K	–	33
2023 Q4	$529K	Hold	117,897	–	–	0.32%	22
2023 Q3	$707K	Sell	117,897 -1	-0%	-$10	0.83%	19
2023 Q2	$1.44M	Hold	117,898	–	–	1.75%	14
2023 Q1	$1.69M	Hold	117,898	–	–	2.21%	12
2022 Q4	$1.77M	Hold	117,898	–	–	1.72%	23
2022 Q3	$4.57M	Hold	117,898	–	–	3.02%	13
2022 Q2	$9.02M	Buy	117,898 +59,482	+102%	+$5.22M	8.22%	2
2022 Q1	$2.84M	Hold	58,416	–	–	2.1%	20
2021 Q4	$4.09M	Hold	58,416	–	–	1.43%	27
2021 Q3	$8.53M	Hold	58,416	–	–	2.51%	19
2021 Q2	$35.8M	Hold	58,416	–	–	8.89%	1
2021 Q1	$40.9M	Hold	58,416	–	–	7.84%	3
2020 Q4	$44M	Buy	+58,416	New	+$40.8M	7.53%	2

Ally Bridge Group's MDVL Position: Q1 2024 in Review

Ally Bridge Group sold out of MedAvail Holdings, Inc. Common Stock (MDVL) in Q1 2024, closing a stake of 117,897 shares — an estimated $529K sold.

Ally Bridge Group first reported a position in MDVL in Q4 2020 and held it in 13 quarters. The position peaked at $44M in Q4 2020. 1 fund tracked by Wall St. Rank holds MDVL as of Q1 2024.

Ally Bridge Group reported no remaining MedAvail Holdings, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Ally Bridge Group sold 117,897 MedAvail Holdings, Inc. Common Stock shares in Q1 2024, an estimated $529K.
Ally Bridge Group first reported a position in MedAvail Holdings, Inc. Common Stock in Q4 2020 and held it in 13 quarters.
Ally Bridge Group's MedAvail Holdings, Inc. Common Stock position peaked at $44M in Q4 2020.
1 fund tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q1 2024.

Based on Ally Bridge Group's 13F filing for Q1 2024, filed 15 May 2024.